Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Star Bulk Carriers Corp (SBLK) vs Viatris Inc (VTRS) Price & Performance

Star Bulk Carriers CorpTrade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

Star Bulk Carriers Corp vs Viatris Inc — how do they compare? Star Bulk Carriers Corp trades at $26.63 (market cap $2.91B), while Viatris Inc trades at $17.58 (market cap $19.79B). The key difference: Viatris Inc is far larger — about 6.8× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (3.95%). Which is the better fit depends on your goals.

SBLKVTRS
Market Cap
$2.91B$19.79B
Sector
IndustrialsHealth
52-Week High
$28.21$17.39
52-Week Low
$16.79$8.74
Enterprise Value
$3.61B$32.00B
Dividend Yield
3.95%2.83%

Returns comparison

Trailing returns across standard periods

About Star Bulk Carriers Corp

Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.

Read more on SBLK

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS